16838 Investors following Aurobindo Pharm. Share this News with them.
0
Like this story, share it with millions of investors on M3
Aurobindo Pharma Q3 PAT at Rs 55.25 cr
Aurobindo Pharma has announced its third quarter results. The company’s Q3 standalone net sales were at Rs 510.8 crore (Rs 5.10 billion) versus Rs 528.4 crore (Rs 5.28 billion), YoY.
Aurobindo Pharma has announced its third quarter results. The company's Q3 standalone net sales were at Rs 510.8 crore (Rs 5.10 billion) versus Rs 528.4 crore (Rs 5.28 billion), YoY.
Its standalone net profit was at Rs 55.25 crore (Rs 552.5 million) versus Rs 60.12 crore (Rs 601.2 million), YoY.